Quantitative assessment of protein replacement in therapeutic plasmapheresis
Aim. To calculate parameters of replacement in which the amount of total protein (TP) in the circulating blood remains above critical level after removal of 17-75% of circulating plasm volume (CPL). Material and methods. Therapeutic plasmapheresis (TPA) was made in 96 patients with rheumatoid arthri...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2003-02-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/29319 |
id |
doaj-74e1b07b53164ddea35ecf3bb24c95f5 |
---|---|
record_format |
Article |
spelling |
doaj-74e1b07b53164ddea35ecf3bb24c95f52020-11-25T02:38:47Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422003-02-01782656826355Quantitative assessment of protein replacement in therapeutic plasmapheresisN N KalininВ Е MovshevD HesterV I PetrovaAim. To calculate parameters of replacement in which the amount of total protein (TP) in the circulating blood remains above critical level after removal of 17-75% of circulating plasm volume (CPL). Material and methods. Therapeutic plasmapheresis (TPA) was made in 96 patients with rheumatoid arthritis, bronchial asthma, systemic lupus erythematosus and other diseases. The plasm was replaced by 0.9% sodium chloride solution, rheopolyglucine and albumin solutions in isovolemic regime. Albumin was given in quantities equivalent to 50-65% of the removed protein. Results. Close correlation was observed between the expected and actual concentrations of total protein in 96 patients who have undergone 206 TPA procedures. In removal of up to 35% CPL protein deficiency is compensated by its mobilization from the deposits and due to protein-synthetizing function of the liver. In removal of 75% and more and in initial hypoproteinemia 50% of the protein should be replaced. Conclusion. It is confirmed that rheopolyglucin can be used for plasm replacement in TPA in patients with hyperproteinemia having no contraindications.https://ter-arkhiv.ru/0040-3660/article/view/29319plasmapheresisvolume of removed plasmisovolemiacolloid-osmotic pressureprotein replacement |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
N N Kalinin В Е Movshev D Hester V I Petrova |
spellingShingle |
N N Kalinin В Е Movshev D Hester V I Petrova Quantitative assessment of protein replacement in therapeutic plasmapheresis Терапевтический архив plasmapheresis volume of removed plasm isovolemia colloid-osmotic pressure protein replacement |
author_facet |
N N Kalinin В Е Movshev D Hester V I Petrova |
author_sort |
N N Kalinin |
title |
Quantitative assessment of protein replacement in therapeutic plasmapheresis |
title_short |
Quantitative assessment of protein replacement in therapeutic plasmapheresis |
title_full |
Quantitative assessment of protein replacement in therapeutic plasmapheresis |
title_fullStr |
Quantitative assessment of protein replacement in therapeutic plasmapheresis |
title_full_unstemmed |
Quantitative assessment of protein replacement in therapeutic plasmapheresis |
title_sort |
quantitative assessment of protein replacement in therapeutic plasmapheresis |
publisher |
"Consilium Medicum" Publishing house |
series |
Терапевтический архив |
issn |
0040-3660 2309-5342 |
publishDate |
2003-02-01 |
description |
Aim. To calculate parameters of replacement in which the amount of total protein (TP) in the circulating blood remains above critical level after removal of 17-75% of circulating plasm volume (CPL). Material and methods. Therapeutic plasmapheresis (TPA) was made in 96 patients with rheumatoid arthritis, bronchial asthma, systemic lupus erythematosus and other diseases. The plasm was replaced by 0.9% sodium chloride solution, rheopolyglucine and albumin solutions in isovolemic regime. Albumin was given in quantities equivalent to 50-65% of the removed protein.
Results. Close correlation was observed between the expected and actual concentrations of total protein in 96 patients who have undergone 206 TPA procedures. In removal of up to 35% CPL protein deficiency is compensated by its mobilization from the deposits and due to protein-synthetizing function of the liver. In removal of 75% and more and in initial hypoproteinemia 50% of the protein should be replaced. Conclusion. It is confirmed that rheopolyglucin can be used for plasm replacement in TPA in patients with hyperproteinemia having no contraindications. |
topic |
plasmapheresis volume of removed plasm isovolemia colloid-osmotic pressure protein replacement |
url |
https://ter-arkhiv.ru/0040-3660/article/view/29319 |
work_keys_str_mv |
AT nnkalinin quantitativeassessmentofproteinreplacementintherapeuticplasmapheresis AT vemovshev quantitativeassessmentofproteinreplacementintherapeuticplasmapheresis AT dhester quantitativeassessmentofproteinreplacementintherapeuticplasmapheresis AT vipetrova quantitativeassessmentofproteinreplacementintherapeuticplasmapheresis |
_version_ |
1724789612542427136 |